According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are $17.17 Million USD. In 2024 the company made an earning of -$36.14 Million USD a decrease over its 2023 earnings that were of -$11.59 Million USD. The earnings displayed on this page is the company's Pretax Income.